{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:07:28Z","timestamp":1770822448012,"version":"3.50.1"},"reference-count":48,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.5858\/arpa.2012-0260-ed","type":"journal-article","created":{"date-parts":[[2013,4,29]],"date-time":"2013-04-29T14:08:53Z","timestamp":1367244533000},"page":"601-602","source":"Crossref","is-referenced-by-count":4,"title":["Accurate Diagnosis of Mesothelioma: More Important Than Ever"],"prefix":"10.5858","volume":"137","author":[{"given":"Timothy Craig","family":"Allen","sequence":"first","affiliation":[{"name":"From the Department of Pathology, University of Texas Health Science Center, Tyler."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"key":"i1543-2165-137-5-601-b01","series-title":"Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma","author":"Al-Taei\n              S,","year":"2012]","unstructured":"Al-Taei\n              S, \n            \n              Salimu\n              J, \n            \n              Lester\n              JF, \n            et al\n          . Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma [published online ahead of print April 10, 2012]. Lung Cancer. doi: http:\/\/dx.doi.org\/10.1016\/j.lungcan.2012.03.008."},{"issue":"1","key":"i1543-2165-137-5-601-b02","series-title":"Biochem Biophys Res Commun","first-page":"140","article-title":"Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells","volume":"421","author":"Yamashita\n              T,","year":"2012]","unstructured":"Yamashita\n              T, \n            \n              Nagano\n              K, \n            \n              Kanasaki\n              SI, \n            et al\n          . Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells [published online ahead of print April 4, 2012]. Biochem Biophys Res Commun. 2012;421(1):140\u2013144. doi: http:\/\/dx.doi.org\/10.1016\/j.bbrc.2012.03.144."},{"key":"i1543-2165-137-5-601-b03","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2012.03.001","article-title":"An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma","author":"Pasello\n              G,","year":"2012]","unstructured":"Pasello\n              G, \n            \n              Ceresoli\n              GL, \n            \n              Favaretto\n              A. \n          \n          An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma [published online ahead of print March 27, 2012]. Cancer Treat Rev. doi: 10.1016\/j.ctrv.2012.03.001."},{"issue":"4","key":"i1543-2165-137-5-601-b04","series-title":"J Thorac Oncol","first-page":"737","article-title":"Pleurectomy\/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma","volume":"7","author":"Lang-Lazdunski\n              L,","year":"2012;","unstructured":"Lang-Lazdunski\n              L, \n            \n              Bille\n              A, \n            \n              Lal\n              R, \n            et al\n          . Pleurectomy\/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol. 2012;7(4):737\u2013743."},{"issue":"5","key":"i1543-2165-137-5-601-b05","series-title":"Gen Thorac Cardiovasc Surg","first-page":"289","article-title":"Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals","volume":"60","author":"Bille\n              A,","year":"2012;","unstructured":"Bille\n              A, \n            \n              Belcher\n              E, \n            \n              Raubenheimer\n              H, \n            et al\n          . Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals. Gen Thorac Cardiovasc Surg. 2012;60(5):289\u2013296."},{"issue":"7","key":"i1543-2165-137-5-601-b06","series-title":"Intern Med","first-page":"707","article-title":"Prognostic factors in malignant pleural mesothelioma: a retrospective study","volume":"51","author":"Suzuki\n              H,","year":"2012;","unstructured":"Suzuki\n              H, \n            \n              Hirashima\n              T, \n            \n              Kobayashi\n              M, \n            et al\n          . Prognostic factors in malignant pleural mesothelioma: a retrospective study. Intern Med. 2012;51(7):707\u2013710."},{"issue":"3","key":"i1543-2165-137-5-601-b07","series-title":"Future Oncol","first-page":"293","article-title":"Systemic treatment of malignant pleural mesothelioma","volume":"8","author":"Grosso\n              F,","year":"2012;","unstructured":"Grosso\n              F, \n            \n              Scagliotti\n              GV. \n          \n          Systemic treatment of malignant pleural mesothelioma. Future Oncol. 2012;8(3):293\u2013305."},{"issue":"4","key":"i1543-2165-137-5-601-b08","series-title":"Anticancer Res","first-page":"1485","article-title":"Complete response and long-term survival in malignant pleural mesothelioma: case report","volume":"32","author":"Takanen\n              S,","year":"2012;","unstructured":"Takanen\n              S, \n            \n              Resuli\n              B, \n            \n              Graziano\n              V, \n            et al\n          . Complete response and long-term survival in malignant pleural mesothelioma: case report. Anticancer Res. 2012;32(4):1485\u20131487."},{"key":"i1543-2165-137-5-601-b09","series-title":"Ind Health","article-title":"Future trends of mesothelioma mortality in Japan based on a risk function","author":"Myojin\n              T,","year":"2012]","unstructured":"Myojin\n              T, \n            \n              Azuma\n              K, \n            \n              Okumura\n              J, \n            \n              Uchiyama\n              I. \n          \n          Future trends of mesothelioma mortality in Japan based on a risk function [published online ahead of print March 28, 2012]. Ind Health. http:\/\/dx.doi.org\/10.2486\/indhealth.MS1184."},{"key":"i1543-2165-137-5-601-b10","series-title":"J Biomed Biotechnol","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/492608","article-title":"Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis","author":"Matsuzaki\n              H,","year":"2012;2012","unstructured":"Matsuzaki\n              H, \n            \n              Maeda\n              M, \n            \n              Lee\n              S, \n            et al\n          . Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis. J Biomed Biotechnol. 2012;2012:492608. doi:10.1155\/2012\/492608."},{"issue":"1","key":"i1543-2165-137-5-601-b11","series-title":"Exp Mol Pathol","first-page":"154","article-title":"Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients","volume":"93","author":"Bahnassy\n              AA,","year":"2012]","unstructured":"Bahnassy\n              AA, \n            \n              Zekri\n              AR, \n            \n              El-Deftar\n              MM, \n            et al\n          . Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients [published online ahead of print April 6, 2012]. Exp Mol Pathol. 2012;93(1):154\u2013161."},{"key":"i1543-2165-137-5-601-b12","series-title":"J Clin Gastroenterol","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31824e901b","article-title":"Serum thioredoxin-1 as a diagnostic marker for malignant peritoneal mesothelioma","author":"Tabata\n              C,","year":"2012]","unstructured":"Tabata\n              C, \n            \n              Terada\n              T, \n            \n              Tabata\n              R, \n            et al\n          . Serum thioredoxin-1 as a diagnostic marker for malignant peritoneal mesothelioma [published online ahead of print March 28, 2012]. J Clin Gastroenterol. doi: 10.1097\/MCG.0b013e31824e901b."},{"key":"i1543-2165-137-5-601-b13","series-title":"Lung Cancer","article-title":"Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)","author":"Cedres\n              S,","year":"2012]","unstructured":"Cedres\n              S, \n            \n              Montero\n              MA, \n            \n              Martinez\n              P, \n            et al\n          . Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM) [published online ahead of print March 27, 2012]. Lung Cancer. http:\/\/dx.doi.org\/10.1016\/j.lungcan.2012.02.022."},{"issue":"4","key":"i1543-2165-137-5-601-b14","series-title":"Pathol Int","first-page":"226","article-title":"A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma","volume":"62","author":"Enomoto\n              Y,","year":"2012;","unstructured":"Enomoto\n              Y, \n            \n              Kasai\n              T, \n            \n              Takeda\n              M, \n            et al\n          . A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma. Pathol Int. 2012;62(4):226\u2013231."},{"issue":"6","key":"i1543-2165-137-5-601-b15","series-title":"Oncol Rep","first-page":"1794","article-title":"Patients with peritoneal mesothelioma lack epidermal growth factor receptor tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors","volume":"27","author":"Kalra\n              N,","year":"2012;","unstructured":"Kalra\n              N, \n            \n              Ashai\n              A, \n            \n              Xi\n              L, \n            et al\n          . Patients with peritoneal mesothelioma lack epidermal growth factor receptor tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors. Oncol Rep. 2012;27(6):1794\u20131800."},{"issue":"1\u20132","key":"i1543-2165-137-5-601-b16","series-title":"Cell Physiol Biochem","first-page":"241","article-title":"PDGF-D\/PDGF-\u03b2\u03b2 receptor-regulated chemotaxis of malignant mesothelioma cells","volume":"29","author":"Okada\n              A,","year":"2012;","unstructured":"Okada\n              A, \n            \n              Yaguchi\n              T, \n            \n              Kanno\n              T, \n            \n              Gotoh\n              A, \n            \n              Nakano\n              T, \n            \n              Nishizaki\n              T. \n          \n          PDGF-D\/PDGF-\u03b2\u03b2 receptor-regulated chemotaxis of malignant mesothelioma cells. Cell Physiol Biochem. 2012;29(1\u20132):241\u2013250."},{"issue":"13","key":"i1543-2165-137-5-601-b17","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1200\/JCO.2011.39.6671","volume":"30","author":"Hollevoet\n              K,","year":"2012]","unstructured":"Hollevoet\n              K, \n            \n              Reitsma\n              JB, \n            \n              Creaney\n              J, \n            et al\n          . Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis [published online ahead of print March 12, 2012]. J Clin Oncol. 2012;30(13):1541\u20131549. doi: 10.1200\/JCO.2011.39.6671."},{"issue":"6","key":"i1543-2165-137-5-601-b18","series-title":"J Clin Pathol","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/jclinpath-2011-200631","article-title":"Epidermal growth factor receptor mutations in malignant pleural and peritoneal mesothelioma","volume":"65","author":"Enomoto\n              Y,","year":"2012]","unstructured":"Enomoto\n              Y, \n            \n              Kasai\n              T, \n            \n              Takeda\n              M, \n            et al\n          . Epidermal growth factor receptor mutations in malignant pleural and peritoneal mesothelioma [published online ahead of print March 12, 2012]. J Clin Pathol. 2012;65(6):522\u2013527. doi:10.1136\/jclinpath-2011-200631."},{"issue":"4","key":"i1543-2165-137-5-601-b19","series-title":"Respiration","first-page":"277","article-title":"Novel intrapleural therapies for malignant diseases","volume":"83","author":"Haas\n              AR,","year":"2012;","unstructured":"Haas\n              AR, \n            \n              Sterman\n              DH. \n          \n          Novel intrapleural therapies for malignant diseases. Respiration. 2012;83(4):277\u2013292."},{"issue":"1","key":"i1543-2165-137-5-601-b20","series-title":"Cancer Lett","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2012.02.034","volume":"322","author":"Izzi\n              V,","year":"2012]","unstructured":"Izzi\n              V, \n            \n              Masuelli\n              L, \n            \n              Tresoldi\n              I, \n            \n              Foti\n              C, \n            \n              Modesti\n              A, \n            \n              Bei\n              R. \n          \n          Immunity and malignant mesothelioma: from mesothelial cell damage to tumor development and immune-response-based therapies [published online ahead of print April 23, 2012]. Cancer Lett. 2012;322(1):18\u201334. doi: 10.1016\/j.canlet.2012.02.034."},{"issue":"3","key":"i1543-2165-137-5-601-b21","series-title":"Anticancer Res","first-page":"1005","article-title":"Chemoprevention of asbestos-linked cancers: a systematic review","volume":"32","author":"Neri\n              M,","year":"2012;","unstructured":"Neri\n              M, \n            \n              Ugolini\n              D, \n            \n              Boccia\n              S, \n            et al\n          . Chemoprevention of asbestos-linked cancers: a systematic review. Anticancer Res. 2012;32(3):1005\u20131013."},{"issue":"1","key":"i1543-2165-137-5-601-b22","series-title":"Tumori","first-page":"166","article-title":"Prospective registry on mesothelioma peritonei treatment (PROMPT): study design and rationale","volume":"98","author":"Cao\n              C,","year":"2012;","unstructured":"Cao\n              C, \n            \n              Yan\n              TD, \n            \n              Morris\n              DL, \n            et al\n          . Prospective registry on mesothelioma peritonei treatment (PROMPT): study design and rationale. Tumori. 2012;98(1):166\u2013171."},{"issue":"5","key":"i1543-2165-137-5-601-b23","series-title":"Arch Pathol Lab Med","first-page":"647","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain\n              AN,","year":"2012;","unstructured":"Husain\n              AN, \n            \n              Colby\n              T, \n            \n              Ordonez\n              N, \n            et al\n          . Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2012;137(5):647\u2013667."},{"issue":"8","key":"i1543-2165-137-5-601-b24","series-title":"Arch Pathol Lab Med","first-page":"1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group","volume":"133","author":"Husain\n              AN,","year":"2009;","unstructured":"Husain\n              AN, \n            \n              Colby\n              TV, \n            \n              Ord\u00f3\u00f1ez\n              NG, \n            et al\n          . Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2009;133(8):1317\u20131331."},{"key":"i1543-2165-137-5-601-b01","series-title":"Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma","author":"Al-Taei\n              S,","year":"2012]","unstructured":"Al-Taei\n              S, \n            \n              Salimu\n              J, \n            \n              Lester\n              JF, \n            et al\n          . Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma [published online ahead of print April 10, 2012]. Lung Cancer. doi: http:\/\/dx.doi.org\/10.1016\/j.lungcan.2012.03.008."},{"issue":"1","key":"i1543-2165-137-5-601-b02","series-title":"Biochem Biophys Res Commun","first-page":"140","article-title":"Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells","volume":"421","author":"Yamashita\n              T,","year":"2012]","unstructured":"Yamashita\n              T, \n            \n              Nagano\n              K, \n            \n              Kanasaki\n              SI, \n            et al\n          . Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells [published online ahead of print April 4, 2012]. Biochem Biophys Res Commun. 2012;421(1):140\u2013144. doi: http:\/\/dx.doi.org\/10.1016\/j.bbrc.2012.03.144."},{"key":"i1543-2165-137-5-601-b03","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2012.03.001","article-title":"An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma","author":"Pasello\n              G,","year":"2012]","unstructured":"Pasello\n              G, \n            \n              Ceresoli\n              GL, \n            \n              Favaretto\n              A. \n          \n          An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma [published online ahead of print March 27, 2012]. Cancer Treat Rev. doi: 10.1016\/j.ctrv.2012.03.001."},{"issue":"4","key":"i1543-2165-137-5-601-b04","series-title":"J Thorac Oncol","first-page":"737","article-title":"Pleurectomy\/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma","volume":"7","author":"Lang-Lazdunski\n              L,","year":"2012;","unstructured":"Lang-Lazdunski\n              L, \n            \n              Bille\n              A, \n            \n              Lal\n              R, \n            et al\n          . Pleurectomy\/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol. 2012;7(4):737\u2013743."},{"issue":"5","key":"i1543-2165-137-5-601-b05","series-title":"Gen Thorac Cardiovasc Surg","first-page":"289","article-title":"Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals","volume":"60","author":"Bille\n              A,","year":"2012;","unstructured":"Bille\n              A, \n            \n              Belcher\n              E, \n            \n              Raubenheimer\n              H, \n            et al\n          . Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals. Gen Thorac Cardiovasc Surg. 2012;60(5):289\u2013296."},{"issue":"7","key":"i1543-2165-137-5-601-b06","series-title":"Intern Med","first-page":"707","article-title":"Prognostic factors in malignant pleural mesothelioma: a retrospective study","volume":"51","author":"Suzuki\n              H,","year":"2012;","unstructured":"Suzuki\n              H, \n            \n              Hirashima\n              T, \n            \n              Kobayashi\n              M, \n            et al\n          . Prognostic factors in malignant pleural mesothelioma: a retrospective study. Intern Med. 2012;51(7):707\u2013710."},{"issue":"3","key":"i1543-2165-137-5-601-b07","series-title":"Future Oncol","first-page":"293","article-title":"Systemic treatment of malignant pleural mesothelioma","volume":"8","author":"Grosso\n              F,","year":"2012;","unstructured":"Grosso\n              F, \n            \n              Scagliotti\n              GV. \n          \n          Systemic treatment of malignant pleural mesothelioma. Future Oncol. 2012;8(3):293\u2013305."},{"issue":"4","key":"i1543-2165-137-5-601-b08","series-title":"Anticancer Res","first-page":"1485","article-title":"Complete response and long-term survival in malignant pleural mesothelioma: case report","volume":"32","author":"Takanen\n              S,","year":"2012;","unstructured":"Takanen\n              S, \n            \n              Resuli\n              B, \n            \n              Graziano\n              V, \n            et al\n          . Complete response and long-term survival in malignant pleural mesothelioma: case report. Anticancer Res. 2012;32(4):1485\u20131487."},{"key":"i1543-2165-137-5-601-b09","series-title":"Ind Health","article-title":"Future trends of mesothelioma mortality in Japan based on a risk function","author":"Myojin\n              T,","year":"2012]","unstructured":"Myojin\n              T, \n            \n              Azuma\n              K, \n            \n              Okumura\n              J, \n            \n              Uchiyama\n              I. \n          \n          Future trends of mesothelioma mortality in Japan based on a risk function [published online ahead of print March 28, 2012]. Ind Health. http:\/\/dx.doi.org\/10.2486\/indhealth.MS1184."},{"key":"i1543-2165-137-5-601-b10","series-title":"J Biomed Biotechnol","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/492608","article-title":"Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis","author":"Matsuzaki\n              H,","year":"2012;2012","unstructured":"Matsuzaki\n              H, \n            \n              Maeda\n              M, \n            \n              Lee\n              S, \n            et al\n          . Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis. J Biomed Biotechnol. 2012;2012:492608. doi:10.1155\/2012\/492608."},{"issue":"1","key":"i1543-2165-137-5-601-b11","series-title":"Exp Mol Pathol","first-page":"154","article-title":"Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients","volume":"93","author":"Bahnassy\n              AA,","year":"2012]","unstructured":"Bahnassy\n              AA, \n            \n              Zekri\n              AR, \n            \n              El-Deftar\n              MM, \n            et al\n          . Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients [published online ahead of print April 6, 2012]. Exp Mol Pathol. 2012;93(1):154\u2013161."},{"key":"i1543-2165-137-5-601-b12","series-title":"J Clin Gastroenterol","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31824e901b","article-title":"Serum thioredoxin-1 as a diagnostic marker for malignant peritoneal mesothelioma","author":"Tabata\n              C,","year":"2012]","unstructured":"Tabata\n              C, \n            \n              Terada\n              T, \n            \n              Tabata\n              R, \n            et al\n          . Serum thioredoxin-1 as a diagnostic marker for malignant peritoneal mesothelioma [published online ahead of print March 28, 2012]. J Clin Gastroenterol. doi: 10.1097\/MCG.0b013e31824e901b."},{"key":"i1543-2165-137-5-601-b13","series-title":"Lung Cancer","article-title":"Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)","author":"Cedres\n              S,","year":"2012]","unstructured":"Cedres\n              S, \n            \n              Montero\n              MA, \n            \n              Martinez\n              P, \n            et al\n          . Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM) [published online ahead of print March 27, 2012]. Lung Cancer. http:\/\/dx.doi.org\/10.1016\/j.lungcan.2012.02.022."},{"issue":"4","key":"i1543-2165-137-5-601-b14","series-title":"Pathol Int","first-page":"226","article-title":"A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma","volume":"62","author":"Enomoto\n              Y,","year":"2012;","unstructured":"Enomoto\n              Y, \n            \n              Kasai\n              T, \n            \n              Takeda\n              M, \n            et al\n          . A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma. Pathol Int. 2012;62(4):226\u2013231."},{"issue":"6","key":"i1543-2165-137-5-601-b15","series-title":"Oncol Rep","first-page":"1794","article-title":"Patients with peritoneal mesothelioma lack epidermal growth factor receptor tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors","volume":"27","author":"Kalra\n              N,","year":"2012;","unstructured":"Kalra\n              N, \n            \n              Ashai\n              A, \n            \n              Xi\n              L, \n            et al\n          . Patients with peritoneal mesothelioma lack epidermal growth factor receptor tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors. Oncol Rep. 2012;27(6):1794\u20131800."},{"issue":"1\u20132","key":"i1543-2165-137-5-601-b16","series-title":"Cell Physiol Biochem","first-page":"241","article-title":"PDGF-D\/PDGF-\u03b2\u03b2 receptor-regulated chemotaxis of malignant mesothelioma cells","volume":"29","author":"Okada\n              A,","year":"2012;","unstructured":"Okada\n              A, \n            \n              Yaguchi\n              T, \n            \n              Kanno\n              T, \n            \n              Gotoh\n              A, \n            \n              Nakano\n              T, \n            \n              Nishizaki\n              T. \n          \n          PDGF-D\/PDGF-\u03b2\u03b2 receptor-regulated chemotaxis of malignant mesothelioma cells. Cell Physiol Biochem. 2012;29(1\u20132):241\u2013250."},{"issue":"13","key":"i1543-2165-137-5-601-b17","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1200\/JCO.2011.39.6671","volume":"30","author":"Hollevoet\n              K,","year":"2012]","unstructured":"Hollevoet\n              K, \n            \n              Reitsma\n              JB, \n            \n              Creaney\n              J, \n            et al\n          . Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis [published online ahead of print March 12, 2012]. J Clin Oncol. 2012;30(13):1541\u20131549. doi: 10.1200\/JCO.2011.39.6671."},{"issue":"6","key":"i1543-2165-137-5-601-b18","series-title":"J Clin Pathol","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/jclinpath-2011-200631","article-title":"Epidermal growth factor receptor mutations in malignant pleural and peritoneal mesothelioma","volume":"65","author":"Enomoto\n              Y,","year":"2012]","unstructured":"Enomoto\n              Y, \n            \n              Kasai\n              T, \n            \n              Takeda\n              M, \n            et al\n          . Epidermal growth factor receptor mutations in malignant pleural and peritoneal mesothelioma [published online ahead of print March 12, 2012]. J Clin Pathol. 2012;65(6):522\u2013527. doi:10.1136\/jclinpath-2011-200631."},{"issue":"4","key":"i1543-2165-137-5-601-b19","series-title":"Respiration","first-page":"277","article-title":"Novel intrapleural therapies for malignant diseases","volume":"83","author":"Haas\n              AR,","year":"2012;","unstructured":"Haas\n              AR, \n            \n              Sterman\n              DH. \n          \n          Novel intrapleural therapies for malignant diseases. Respiration. 2012;83(4):277\u2013292."},{"issue":"1","key":"i1543-2165-137-5-601-b20","series-title":"Cancer Lett","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2012.02.034","volume":"322","author":"Izzi\n              V,","year":"2012]","unstructured":"Izzi\n              V, \n            \n              Masuelli\n              L, \n            \n              Tresoldi\n              I, \n            \n              Foti\n              C, \n            \n              Modesti\n              A, \n            \n              Bei\n              R. \n          \n          Immunity and malignant mesothelioma: from mesothelial cell damage to tumor development and immune-response-based therapies [published online ahead of print April 23, 2012]. Cancer Lett. 2012;322(1):18\u201334. doi: 10.1016\/j.canlet.2012.02.034."},{"issue":"3","key":"i1543-2165-137-5-601-b21","series-title":"Anticancer Res","first-page":"1005","article-title":"Chemoprevention of asbestos-linked cancers: a systematic review","volume":"32","author":"Neri\n              M,","year":"2012;","unstructured":"Neri\n              M, \n            \n              Ugolini\n              D, \n            \n              Boccia\n              S, \n            et al\n          . Chemoprevention of asbestos-linked cancers: a systematic review. Anticancer Res. 2012;32(3):1005\u20131013."},{"issue":"1","key":"i1543-2165-137-5-601-b22","series-title":"Tumori","first-page":"166","article-title":"Prospective registry on mesothelioma peritonei treatment (PROMPT): study design and rationale","volume":"98","author":"Cao\n              C,","year":"2012;","unstructured":"Cao\n              C, \n            \n              Yan\n              TD, \n            \n              Morris\n              DL, \n            et al\n          . Prospective registry on mesothelioma peritonei treatment (PROMPT): study design and rationale. Tumori. 2012;98(1):166\u2013171."},{"issue":"5","key":"i1543-2165-137-5-601-b23","series-title":"Arch Pathol Lab Med","first-page":"647","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain\n              AN,","year":"2012;","unstructured":"Husain\n              AN, \n            \n              Colby\n              T, \n            \n              Ordonez\n              N, \n            et al\n          . Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2012;137(5):647\u2013667."},{"issue":"8","key":"i1543-2165-137-5-601-b24","series-title":"Arch Pathol Lab Med","first-page":"1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group","volume":"133","author":"Husain\n              AN,","year":"2009;","unstructured":"Husain\n              AN, \n            \n              Colby\n              TV, \n            \n              Ord\u00f3\u00f1ez\n              NG, \n            et al\n          . Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2009;133(8):1317\u20131331."}],"container-title":["Archives of Pathology and Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/137\/5\/article-p601.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/137\/5\/601\/1612147\/arpa_2012-0260-ed.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/137\/5\/article-p601.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/137\/5\/article-p601.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:59:09Z","timestamp":1770771549000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/137\/5\/article-p601.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":48,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2012-0260-ed","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}